Author Health
Mitchell Maffeo serves as the Head of Product at Author Health, leading the development of a tech platform for team-based mental health care for Medicare patients since September 2023. Prior to this role, Mitchell worked at Hometap as a Principal Product Manager and Senior Product Manager, facilitating access to home equity for financial needs. At Kyruus, Mitchell was a Product Manager, focusing on Search API and Indexing products to optimize patient-provider matching. Earlier experience includes a Product Manager role at CozyKin, where the company connected families with affordable childcare, and a Product Manager position at Wellist, which aimed to enhance patient care through digital solutions. Mitchell holds a Bachelor of Arts degree in Economics-Mathematics from Colby College.
This person is not in any teams
This person is not in any offices
Author Health
1 followers
Author Health is the first platform to provide comprehensive care and treatment for Medicare Advantage recipients with serious mental illness (SMI) and substance use disorders (SUD). Author Health offers a team-based approach to care, bringing together specialized physicians, nurses, therapists, and community health workers to deliver a mix of virtual and in-person care for individuals who are often disconnected from the traditional healthcare system. This approach overcomes workforce shortages in behavioral health fields and geographic barriers to care, and blends excellent medical treatment with the foundation of behavior change: relationships. Through this model, patients and their caregivers are given an avenue to reconnect with healthcare providers and receive personalized and comprehensive treatment outside of institutions and in their communities. Led by some of the nation’s foremost leaders in healthcare administration, behavioral health, and integrated care, the company launched from stealth in 2023 with $115 million in financing led by General Atlantic with participation from Flare Capital Partners. Author Health is currently serving patients in Florida and Texas, with nationwide coverage coming soon.